Literature DB >> 18182655

Predicting outcomes in metastatic melanoma.

Charles M Balch1, Seng-Jaw Soong.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18182655     DOI： 10.1200/JCO.2007.13.8123

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.

Authors:  Dusan Bogunovic; David W O'Neill; Ilana Belitskaya-Levy; Vladimir Vacic; Yi-Lo Yu; Sylvia Adams; Farbod Darvishian; Russell Berman; Richard Shapiro; Anna C Pavlick; Stefano Lonardi; Jiri Zavadil; Iman Osman; Nina Bhardwaj
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

2.  Overview of Subcutaneous Metastatic Melanoma.

Authors:  Nicola Mozzillo
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

3.  Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells.

Authors:  Jiaying Zhou; Yabin Cheng; Liren Tang; Magdalena Martinka; Sunil Kalia
Journal:  Oncotarget       Date:  2017-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.